my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
The increasing cost of treatments for chronic myeloid leukemia (CML) in the United States has reached unsustainably high levels and may be leaving many patients under- or untreated because they cannot afford care, according to a Blood Forum article supported by nearly 120 CML experts from more than more
Despite treatment with imatinib, a drug that targets chronic myeloid leukemia (CML, some patients may continue to be at risk for relapse because a tiny pool of stem cells is resistant to treatment and may even accumulate additional genetic aberrations, eventually leading to disease progression and r more
Novartis has received a positive opinion recommending European Union approval of Tasigna® (nilotinib), a selective targeted therapy for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. The Committee for Medicinal Products for more
Publication date: Available online 2 May 2013Source:European Journal of Pharmaceutical Sciences Author(s): Eva Kralj , Simon Žakelj , Jurij Trontelj , Tadej Pajič , Irena Preložnik Zupan , Peter Černelč , Barbara Ostanek , Janja Marc , Albin Kristl The success of imatinib therapy in chr more
MYC antagonizes the differentiation induced by imatinib in chronic myeloid leukemia cells through downregulation of p27KIP1 Oncogene 32, 2239 (25 April 2013). doi:10.1038/onc.2012.246 Authors: M T Gómez-Casares, E García-Alegria, C E López-Jorge, N Ferrándiz, R Blanco, S Alva more
STAT5 fulfills essential roles in hematopoietic stem cell (HSC) self-renewal and chronic myeloid leukemia (CML), a prototypical stem cell malignancy. However, the specific contributions of the two related genes STAT5A and STAT5B have not been determined. In this study, we used a RNAi-based strategy more
Introduction Global Markets Direct’s, 'Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2012', provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) therapeutic pipeline. This report provides information on the therapeutic developm more
Introduction Global Markets Direct’s, 'Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Chronic Myelocytic Leukemia (CML, Chron more
BMI View: While South Korea's research and development (R&D) environment may be attractive to investors, its pharmaceutical market environment is rather uncertain given the dispute between pharmaceutical companies and the government over pharmaceutical price cuts. We hold to our view that, if the go more
Skip to content Management Team Board of Directors Scientific Advisors Clinical Advisors Contact Us Directions FLT3 Kinase AURORA Kinase BRAF Kinase Press Releases Events Ambit's powerful profiling technology, innovative licensing strategy, history of kinase expertise and pipeline of cancer therapeu more
Overview Business Strategy Management Team Board Of Directors Scientific Advisory Board Clinical Advisory Board From Heparin to Glycodrugs Endotis Pharma Drug Discovery Engine Targeted Diseases R&D Programs Targeted Diseases 1.1 Thrombosis The thrombosis market represents an estimated 45 million pat more
Corporate Overview History Management Team Board of Directors Collaborators & Advisors Current Investors Overview Therapeutic Areas Pipeline Publications Press Releases Presentations Careers Pipeline CD200 fusion protein (CD200Fc) CD200 is a transmembrane protein broadly expressed on a variety of ce more
Watchlist
This is where you can add this topic to your personal favourites
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
